Gabelli Funds’s Akcea Therapeutics Inc AKCA Stock Holding History

Gabelli Funds’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-599,625	Closed	-$10.9M	–	1282
2020 Q3	$10.9M	Buy	+599,625	New	+$8.51M	0.08%	291

Gabelli Funds's AKCA Position: Q4 2020 in Review

Gabelli Funds sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 599,625 shares — an estimated $10.9M sold.

Gabelli Funds first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $10.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Gabelli Funds reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Gabelli Funds sold 599,625 Akcea Therapeutics Inc shares in Q4 2020, an estimated $10.9M.
Gabelli Funds first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Gabelli Funds's Akcea Therapeutics Inc position peaked at $10.9M in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Gabelli Funds's 13F filing for Q4 2020, filed 5 Feb 2021.